Neuro Event Labs’ CEO Kaapo Annala was interviewed by Good News In Finland, a journal dedicated to Finnish innovations and technologies. In this in-depth interview, Kaapo walks us through our innovation Nelli, technologies behind it and most importantly, how it helps doctors to provide better, individualized treatment of patients.
In its recent report on Finland’s national Artificial Intelligence Programme, the Finnish Ministry of Economic Affairs and Employment introduces Neuro Event Labs as one of the leading companies utilizing AI. AI has been nationally recognized as one of the most important technologies of our time, capable of creating new economic growth and promoting wellbeing.
Martta, 21, has epilepsy. As part of her treatment planning, she used the Nelli Home device from Neuro Event Labs. The device is designed for epilepsy monitoring at the patient’s own home. Nelli helped doctors find exactly the right treatment option for Martta, resulting in fewer night-time epilepsy seizures, for example.
In cooperation with Helsinki University Hospital and University of Pisa, Neuro Event Labs has developed and proven a method to extract clinically useful information from infant videos to assess child’s neurodevelopment. In this peer-reviewed study, the method has been used in early identification of cerebral palsy (CP). Artificial Intelligence Identifies Key Patterns From Video Footage Of Infant Movements